ArticleNeuropsychiatric disease and treatment2025
Machine Learning and Interpretability Study for Predicting 30-Day Unplanned Readmission Risk of Schizophrenia: A Retrospective Study.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To build a 30-day unplanned readmission (UPR) risk prediction model based on machine learning (ML) and SHapley Additive exPlanation (SHAP) with data obtained from the electronic medical records (EMRs) of patients with schizophrenia, so as to provide support for early intervention in clinical treatment. Patients and Methods: This retrospective study selected 1,123 patients with schizophrenia who were hospitalized at least once from January 1, 2021 to June 30, 2024 according to their EMRs. Models were constructed after screening variables using the multiple linear regression and feature importance methods. The model was constructed using five ML algorithms: logistic regression (LR), decision tree (DT), random forest (RF), support vector machine (SVM), and extreme gradient boosting (XGB). The area under the receiver operating characteristic curve (AUC) and SHAP were applied to verify the predictive power and interpretability, respectively, of the five models. Results: The 30-day UPR rate was 30.54% (343/1,123). The important risk factors were number of somatic comorbid diseases, duration of the disease course, length of the latest hospital stay, drug withdrawal history, and sex. The AUC values of the LR, DT, RF, XGB, and SVM models for predicting the 30-day UPR in the testing set were 0.794, 0.717, 0.823, 0.830, and 0.810, respectively. Conclusion: An XGB risk prediction model can accurately evaluate the 30-day UPR of patients with schizophrenia. Combined with SHAP, it can provide patients with personalized risk predictions, thereby assisting medical staff in achieving early discharge plans and transitional care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.